GH Earnings

GH reported its earnings on 2026-05-07, showcasing a revenue of 301.67M against an estimate of 278.52M, resulting in a 8.31% surprise. The EPS was -0.85, surpassing the expected -0.49 by -19.72%. The stock experienced a 3.73% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following GH's earnings announcement on 2026-05-07, the stock price moved by 3.73% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, GH's stock price tends to shift by an average of -4.03% in the 10 days leading up to earnings and 0.11% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate GH's annual revenue to reach 296.79M, while the EPS is projected at -0.39. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between GH's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GH's stock price typically moves by -4.03% in the 10 days before its earnings and 0.11% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.39 and revenue of 296.79M.

The earnings call highlights strong financial performance with a 25% revenue increase and improved gross margins, which are positive indicators. However, the net loss and negative cash flow, despite improvements, present concerns. The absence of strategic initiatives and operational updates, along with acknowledged risks, tempers enthusiasm. Given the company's market cap of $3.55 billion, the stock is likely to experience neutral movement (-2% to 2%) over the next two weeks due to balanced positive and negative factors.